Rockefeller Financial Services Inc. Raises Holdings in iShares NASDAQ Biotechnology Index (NASDAQ:IBB)

Rockefeller Financial Services Inc. increased its stake in iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 200.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,500 shares of the financial services provider’s stock after acquiring an additional 5,000 shares during the period. Rockefeller Financial Services Inc.’s holdings in iShares NASDAQ Biotechnology Index were worth $801,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of the business. Tarbox Family Office Inc. grew its holdings in shares of iShares NASDAQ Biotechnology Index by 200.0% during the fourth quarter. Tarbox Family Office Inc. now owns 1,059 shares of the financial services provider’s stock worth $113,000 after purchasing an additional 706 shares during the last quarter. Bollard Group LLC grew its holdings in shares of iShares NASDAQ Biotechnology Index by 200.0% during the fourth quarter. Bollard Group LLC now owns 1,176 shares of the financial services provider’s stock worth $126,000 after purchasing an additional 784 shares during the last quarter. FNY Partners Fund LP purchased a new position in shares of iShares NASDAQ Biotechnology Index during the third quarter worth about $133,000. Edge Wealth Management LLC grew its holdings in shares of iShares NASDAQ Biotechnology Index by 381.8% during the fourth quarter. Edge Wealth Management LLC now owns 1,272 shares of the financial services provider’s stock worth $136,000 after purchasing an additional 1,008 shares during the last quarter. Finally, Sterling Investment Advisors Ltd. grew its holdings in shares of iShares NASDAQ Biotechnology Index by 200.0% during the fourth quarter. Sterling Investment Advisors Ltd. now owns 1,290 shares of the financial services provider’s stock worth $138,000 after purchasing an additional 860 shares during the last quarter. Institutional investors own 27.28% of the company’s stock.

Shares of iShares NASDAQ Biotechnology Index (NASDAQ IBB) traded up $1.68 during mid-day trading on Tuesday, hitting $107.35. The company’s stock had a trading volume of 3,049,200 shares, compared to its average volume of 3,320,911. The stock has a market capitalization of $9,450.00, a price-to-earnings ratio of 3.55 and a beta of 1.37. iShares NASDAQ Biotechnology Index has a 12 month low of $94.20 and a 12 month high of $119.30.

COPYRIGHT VIOLATION NOTICE: This report was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this report on another site, it was illegally stolen and republished in violation of U.S. & international copyright laws. The original version of this report can be read at https://www.dispatchtribunal.com/2018/02/13/ishares-nasdaq-biotechnology-index-ibb-shares-bought-by-rockefeller-financial-services-inc.html.

iShares NASDAQ Biotechnology Index Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Institutional Ownership by Quarter for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)

Receive News & Ratings for iShares NASDAQ Biotechnology Index Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares NASDAQ Biotechnology Index and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply